Percutaneous Edge-to-Edge Repair in Congenital Heart Disease
Author Information
Author(s): Silini Alexandre, Iriart Xavier
Primary Institution: University Hospital of Bordeaux, Department of Pediatric and Adult Congenital Cardiology, France
Hypothesis
Is percutaneous edge-to-edge repair a safe and effective treatment for atrioventricular regurgitation in patients with congenital heart disease?
Conclusion
Percutaneous edge-to-edge repair appears to be a safe, effective therapeutic option for atrioventricular regurgitation in patients with congenital heart disease who are at high risk for surgical complications.
Supporting Evidence
- Percutaneous edge-to-edge repair has shown short-term clinical and hemodynamic improvements.
- Most cases reported significant improvement in heart failure symptoms, mainly dyspnea.
- No intraprocedural deaths have been reported.
- One death due to multiorgan failure was reported 5 days after the procedure.
Takeaway
Doctors are trying a new way to fix heart valves in kids and young adults with heart problems, and it seems to help them feel better without needing big surgeries.
Methodology
The authors reviewed case reports and series of patients with congenital heart disease and atrioventricular regurgitation treated with transcatheter edge-to-edge repair.
Potential Biases
The nature of case reports may lead to a biased selection of successful procedures.
Limitations
The review is based on case reports, which may introduce bias and limit the generalizability of the results.
Participant Demographics
Patients with congenital heart disease, including those with systemic right ventricle and systemic left ventricle.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website